SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-007375
Filing Date
2022-05-04
Accepted
2022-05-04 16:05:25
Documents
77
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q srpt-20220331.htm   iXBRL 10-Q 3370139
2 EX-10.1 srpt-ex10_1.htm EX-10.1 98613
3 EX-31.1 srpt-ex31_1.htm EX-31.1 14901
4 EX-31.2 srpt-ex31_2.htm EX-31.2 15014
5 EX-32.1 srpt-ex32_1.htm EX-32.1 10596
6 EX-32.2 srpt-ex32_2.htm EX-32.2 10424
  Complete submission text file 0000950170-22-007375.txt   10472180

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT srpt-20220331_pre.xml EX-101.PRE 331650
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT srpt-20220331_cal.xml EX-101.CAL 71323
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT srpt-20220331_lab.xml EX-101.LAB 443086
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT srpt-20220331.xsd EX-101.SCH 61240
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT srpt-20220331_def.xml EX-101.DEF 183068
71 EXTRACTED XBRL INSTANCE DOCUMENT srpt-20220331_htm.xml XML 1988510
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14895 | Film No.: 22891474
SIC: 2834 Pharmaceutical Preparations